Should statins be considered for the management of mucormycosis in COVID-19?

Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102162. doi: 10.1016/j.dsx.2021.05.035. Epub 2021 Jun 5.
No abstract available

Keywords: Antifungal; COVID-19; Diabetes; Mucormycosis; Statin.

Publication types

  • Letter

MeSH terms

  • Antifungal Agents / therapeutic use
  • COVID-19 / complications
  • COVID-19 / metabolism*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Hyperglycemia / metabolism*
  • India
  • Mucormycosis / complications
  • Mucormycosis / metabolism
  • Mucormycosis / prevention & control*
  • SARS-CoV-2

Substances

  • Antifungal Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors